Notably, the link between caffeine intake and cerebrospinal fluid (CSF) biomarkers, including amyloid peptides Aβ and tau protein, in individuals presenting with MCI and AD has been largely overlooked. This evidence concerns the gene MAPT and Alzheimer disease.